Articles about 'Alzheimer's Research UK

Cambridge researchers have discovered why living in a disadvantaged neighbourhood may be linked to an increase in an individual’s risk of dementia.

Animal research is an essential part of the drug discovery process - allowing scientists to test new treatments that could help change people’s lives.

A simple blood test is being rolled out across the UK as part of a new study to detect early signs of dementia decades before it develops and help identify treatments.

Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.

Cambridge researchers are helping lead countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK’s shocking diagnosis rate.

Cambridge scientists have shown that the hypothalamus, a key region of the brain involved in controlling appetite, is different in the brains of people who are overweight and people with obesity when compared to people who are a healthy weight.

Cambridge is to lead a £9.5m research platform that aims to transform the way survivors of traumatic brain injury are diagnosed and treated in the UK, the Medical Research Council (MRC) announced today.

Cambridge scientists have shown how the brain’s ability to clear out toxic proteins is impaired in Huntington’s disease and other forms of dementia – and how, in a study in mice, a repurposed HIV drug was able to restore this function, helping prevent this dangerous build-up and slowing progression of the disease.

Water – which makes up the majority of every cell in the body – plays a key role in how proteins, including those associated with Parkinson’s disease, fold, misfold, or clump together, according to a new study.

Researchers have shown that aggregation of amyloid-beta, one of two key proteins implicated in Alzheimer’s disease, causes cells to overheat and ‘fry like eggs.’